Global /South Korea /Healthcare /Biotechnology /456070

ENCell Co., Ltd.

456070

• KRX: 456070 • Delayed

15,580KRW -4.3%

9.99 USD

As of 8 June 2026, ENCell Co., Ltd. has a market cap of $116.85M USD, ranking #24476 globally and #1136 in South Korea. It ranks #2190 in the Healthcare sector, and #422 in the Biotechnology industry.

Global Rank

24476

Country Rank

1136

Sector Rank

2190

Industry Rank

422

Key Stats

Market Cap

$116.85MUSD

179.1B KRW

Enterprise Value

$98.47MUSD

153.61B KRW

Revenue (TTM)

$3.43MUSD

5.26B KRW

EBITDA (TTM)

-$8.46MUSD

-13.2B KRW

Net Income (TTM)

-$10.51MUSD

-16.11B KRW

EBITDA Margin

-251%

PS Ratio

34.1

PB Ratio

4.5

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Biotechnology

Founded

2018

Website

encellinc.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-4.3%	2.2%	3%	-4%	32%	-10%	14%	-74%	-74%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	456070 이엔셀 주식회사 Ordinary Shares ISIN: KR7456070002 Shares Out.: Shares Outstanding: 11.029M¹ Shares Float: 7.271M² TV: TradingView: KRX: 456070 SA: Stock Analysis: KRX: 456070 YF: Yahoo Finance: 456070.KS GF: Google Finance: KRX: 456070 BA: Barron's: 456070 MS: Morningstar: XKRX: 456070	15,580 KRW	TV: TradingView: KRX: 456070 SA: Stock Analysis: KRX: 456070 YF: Yahoo Finance: 456070.KS GF: Google Finance: KRX: 456070 BA: Barron's: 456070 MS: Morningstar: XKRX: 456070

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About ENCell Co., Ltd.

ENCell Co., Ltd. develops cell/gene-based biopharmaceutical products in South Korea. The company develops EN00, an allogeneic umbilical cord-derived mesenchymal stem cell treatment for Charcot-Marie-Tooth disease. It also provides contracting development and manufacturing services for biopharmaceutical products. The company was founded in 2018 and is based in Seoul, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 38K%	35.5	South Korea
Celltrion, Inc. KRX: 068270	$27.89B 42.76T KRW 24K%	43.8	South Korea
ALTEOGEN Inc. KRX: 196170	$13.27B 20.33T KRW 11K%	146.6	South Korea
HLB Co., Ltd. KRX: 028300	$5.46B 8.37T KRW 5K%	-	South Korea
Peptron, Inc. KRX: 087010	$3.96B 6.07T KRW 3K%	-	South Korea
SK bioscience Co.,Ltd. KRX: 302440	$2.23B 3.42T KRW 2K%	-	South Korea

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 156K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 137K%	19.0	United States
argenx SE EBR: ARGX	$48.08B 41.39B EUR 41K%	39.9	Netherlands
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 37K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.72B 33.71B CHF 36K%	37.2	Switzerland
Natera, Inc. NASDAQ: NTRA	$27.6B 24K%	-	United States

chevron_leftBack